{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T17:33:45Z","timestamp":1781976825031,"version":"3.54.5"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      This study aimed to evaluate the role of adjuvant HPV vaccination in women undergoing conization for cervical intraepithelial neoplasia. This prospective study assessed factors influencing recurrence in patients undergoing conization for high-grade cervical dysplasia. After conization, patients were counseled on the potential benefits of vaccination. We compared outcomes between two groups: women who underwent conization with adjuvant human papillomavirus (HPV) vaccination and observation versus conization with observation only. Data from 281 patients were analyzed, comprising 168 (59.8%) patients in the conization-only group and 113 (40.2%) patients in the conization-plus vaccination group. Vaccinated patients were younger than nonvaccinated patients (38 vs. 45 years,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u20050.001). Positive surgical margins were more frequently observed in the vaccinated group compared with the nonvaccinated group (9.7 vs. 3.6%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.038). Median follow-up was shorter in the vaccinated group, although this difference was not statistically significant (24.9 vs. 27.8 months;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.395). The risk of developing HPV-related lesions was similar between the vaccinated and nonvaccinated groups (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.594, log-rank test). Likewise, the need for reconization did not differ significantly between the groups (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.593, log-rank test). Multivariate analysis showed no significant impact of HPV vaccination on postoperative outcomes [hazard ratio (HR): 0.50, 95% confidence interval (CI): 0.15\u20131.68) for any lesion; HR: 0.90, 95% CI: 0.47\u20131.73 for reconization]. This study indicates that adjuvant HPV vaccination does not significantly affect short-term outcomes in women undergoing conization for cervical dysplasia. Ongoing randomized trials will provide more robust evidence to clarify the role of adjuvant vaccination in this setting.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/cej.0000000000000971","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T08:00:56Z","timestamp":1745568056000},"page":"243-249","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Adjuvant VaccInation After Conization for the Treatment for CervicAL Dysplasia"],"prefix":"10.1097","volume":"35","author":[{"given":"Carlotta","family":"Caia","sequence":"first","affiliation":[{"name":"Gynecologic Oncologic Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"De Maria","sequence":"additional","affiliation":[{"name":"Gynecologic Oncologic Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Sopracordevole","sequence":"additional","affiliation":[{"name":"Gynecological Oncology Unit, Centro di Riferimento Oncologico-National Cancer Institute, Aviano"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ciavattini","sequence":"additional","affiliation":[{"name":"Woman\u2019s Health Sciences Department, Gynecologic Section, Polytechnic University of Marche, Ancona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jvan","family":"Casarin","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, \u2018Filippo Del Ponte\u2019 Hospital, University of Insubria, Varese"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Ghezzi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, \u2018Filippo Del Ponte\u2019 Hospital, University of Insubria, Varese"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Vizzielli","sequence":"additional","affiliation":[{"name":"Department of Medical Area (DAME), University of Udine, \u2018Santa Maria Della Misericordia\u2019 University Hospital, Azienda Sanitaria Universitaria Friuli Centrale, Clinic of Obstetrics and Gynecology, Udine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Chiappa","sequence":"additional","affiliation":[{"name":"Gynecologic Oncologic Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Leone Roberti Maggiore","sequence":"additional","affiliation":[{"name":"Gynecologic Oncologic Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Valsecchi","sequence":"additional","affiliation":[{"name":"Gynecologic Oncologic Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Scambia","sequence":"additional","affiliation":[{"name":"Gynecologic Oncology Unit, Department of Women, Children and Public Health Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Raspagliesi","sequence":"additional","affiliation":[{"name":"Gynecologic Oncologic Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Corso","sequence":"additional","affiliation":[{"name":"Department of Oncology and Hemato-Oncology, University of Milan."},{"name":"Division of Breast Surgery, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Bogani","sequence":"additional","affiliation":[{"name":"Gynecologic Oncologic Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,4,18]]},"reference":[{"key":"R1-20260327","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S1470-2045(22)00334-5","article-title":"Comparative effectiveness and risk of preterm birth of local treatments for cervical intraepithelial neoplasia and stage IA1 cervical cancer: a systematic review and network meta-analysis.","volume":"23","author":"Athanasiou","year":"2022","journal-title":"Lancet Oncol"},{"key":"R2-20260327","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ajog.2011.01.003","article-title":"Cervical conization and the risk of preterm delivery.","volume":"205","author":"Bevis","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"R3-20260327","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ygyno.2020.08.025","article-title":"Recurrence rate after loop electrosurgical excision procedure (LEEP) and laser conization: a 5-year follow-up study.","volume":"159","author":"Bogani","year":"2020","journal-title":"Gynecol Oncol"},{"key":"R4-20260327","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3390\/vaccines8040717","article-title":"Assessing the long-term role of vaccination against HPV after loop electrosurgical excision procedure (LEEP): a propensity-score matched comparison.","volume":"8","author":"Bogani","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"R6-20260327","doi-asserted-by":"crossref","first-page":"e2437703","DOI":"10.1001\/jamanetworkopen.2024.37703","article-title":"Cost-effectiveness of 9-valent HPV vaccination for patients treated for high-grade cervical intraepithelial neoplasia in the UK.","volume":"7","author":"Cherif","year":"2024","journal-title":"JAMA Netw Open"},{"key":"R7-20260327","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3390\/vaccines9050410","article-title":"Adjuvant HPV vaccination to prevent recurrent cervical dysplasia after surgical treatment: a meta-analysis.","volume":"9","author":"Di Donato","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"R8-20260327","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3390\/vaccines10020239","article-title":"HPV vaccination after primary treatment of HPV-related disease across different organ sites: a multidisciplinary comprehensive review and meta-analysis.","volume":"10","author":"Di Donato","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"R9-20260327","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ygyno.2018.08.033","article-title":"SPERANZA project: HPV vaccination after treatment for CIN2.","volume":"151","author":"Ghelardi","year":"2018","journal-title":"Gynecol Oncol"},{"key":"R11-20260327","doi-asserted-by":"crossref","first-page":"e1401","DOI":"10.1136\/bmj.e1401","article-title":"Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data.","volume":"344","author":"Joura","year":"2012","journal-title":"BMJ"},{"key":"R12-20260327","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1405044","article-title":"A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women.","volume":"372","author":"Joura","year":"2015","journal-title":"N Engl J Med"},{"key":"R13-20260327","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/ijgc-2022-004213","article-title":"The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) consensus statement on the management of vaginal intraepithelial neoplasia.","volume":"33","author":"Kesic","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"R14-20260327","doi-asserted-by":"crossref","first-page":"430.e1","DOI":"10.1016\/j.ajog.2023.11.1235","article-title":"Risk of progression of cervical intraepithelial neoplasia grade 2 in human papillomavirus-vaccinated and unvaccinated women: a population-based cohort study.","volume":"230","author":"Krog","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"R15-20260327","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1186\/s12885-020-07025-7","article-title":"Adjuvant VACcination against HPV in surgical treatment of Cervical Intra-epithelial Neoplasia (VACCIN study) a study protocol for a randomised controlled trial.","volume":"20","author":"van de Laar","year":"2020","journal-title":"BMC Cancer"},{"key":"R16-20260327","doi-asserted-by":"crossref","first-page":"2078626","DOI":"10.1080\/21645515.2022.2078626","article-title":"Effectiveness, immunogenicity, and safety of the quadrivalent HPV vaccine in women and men aged 27-45 years.","volume":"18","author":"Maldonado","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"R17-20260327","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejogrb.2023.08.369","article-title":"European consensus statement on expert colposcopy.","volume":"290","author":"McGee","year":"2023","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R19-20260327","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1001\/jama.2023.13174","article-title":"Cervical cancer screening: a review.","volume":"330","author":"Perkins","year":"2023","journal-title":"JAMA"},{"key":"R20-20260327","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-9378-4-8","article-title":"Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline.","volume":"4","author":"Schiffman","year":"2009","journal-title":"Infect Agent Cancer"},{"key":"R22-20260327","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc2050","article-title":"The natural history of cervical HPV infection: unresolved issues.","volume":"7","author":"Woodman","year":"2007","journal-title":"Nat Rev Cancer"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000971","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T06:00:49Z","timestamp":1774591249000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,18]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/cej.0000000000000971","relation":{},"ISSN":["0959-8278","1473-5709"],"issn-type":[{"value":"0959-8278","type":"print"},{"value":"1473-5709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,18]]}}}